Not finding it? Sign in to also search OpenAlex live.
-
Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta F. Fiocco, +10 more
2citations -
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study2025 The Journal of Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Roy Fleischmann, Robert L. Wong, Karissa L. Lozenski, Yoshiya Tanaka, Vivian P. Bykerk, +9 more
2citations -
Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series2022 Journal of Oncology Pharmacy Practice article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Emma C. Bernsen, LM Hanff, LM Haveman, Bastiaan B.J. Tops, Maaike van der Lee, Jesse Joachim Swen, +2 more
2citations -
Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritis
Isabell S Nevins, Joy Ardjuna van der Pol, Lotte van Ouwerkerk, G S Helmich, Reinhard Bos, Sjoerd M. van der Kooij, +8 more
1citations -
Baseline Interleukin‐10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease‐Modifying Antirheumatic Drug Naive and Anti–Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis2026 Arthritis & Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access
Jinqi Liu, Y. Li, Kai Fu, Chun Wu, Peter H Schafer, S. Connolly, +9 more
1citations -
Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management—a multicentre, randomised, open-label trial
Agnes E M Looijen, Hamit Harun Dağ, Judith W Heutz, Floris A van Gaalen, Mirjam C. Hegeman, Jos H van der Kaap, +10 more
0citations -
P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results2020 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Neil D McKay, Désirée M F M van der Heijde, René Westhovens, William F. C. Rigby, D. W. T. CHING, Beatrix Bartók, +10 more
0citations -
THU0188 EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 32020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
Daniel Aletaha, René Westhovens, Cécile Gaujoux-Viala, Giovanni Adami, A K Matsumoto, Paul Bird, +6 more
0citations -
Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
María Queralt Salas, Dirk‐Jan Eikema, Linda Köster, Johan A. Maertens, Jakob Robert Passweg, Jürgen Finke, +18 more
0citations -
OP0243 SINGLE-CELL RNA SEQUENCING OF ACPA-ENRICHED B CELLS REVEALED A CD11c+ ATYPICAL B CELL GENE SIGNATURE IN RHEUMATOID ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Yasuo Nagafuchi, Linda M. Slot, Deimantė Šimaitė, Aleida M. Bakker, Erik B. van den Akker, Tom W. J. Huizinga, +3 more
0citations -
Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials
Josef S Smolen, Peter Charles Taylor, Gerd Burmester, Yoshiya Tanaka, Tsutomu Takeuchi, Jeffrey R. Curtis, +7 more
0citations -
OP0323 HAND-DOMINANT JOINT INVOLVEMENT PATTERN ASSOCIATES WITH FAVORABLE, AND POLYARTHRITIS WITH UNFAVORABLE, TREATMENT RESPONSE TO BOTH csDMARDs AND bDAMRDs IN EARLY RHEUMATOID ARTHRITIS: A COMBINED ANALYSIS OF NORD-STAR AND BeSt TRIALS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Yasuo Nagafuchi, Tjardo Daniël Maarseveen, Kristina Lend, Arvid Dahlstrand Rudin, B. Gudbjornsson, D. Nordström, +15 more
0citations -
P115 Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study2025 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Maya H Buch, Patrick Verschueren, Roberto Felice Caporali, Tom W. J. Huizinga, Edmund V Ekoka Omoruyi, Dick de Vries, +2 more
0citations -
ABS0815 EFFICACY AND SAFETY OF TOFACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS NAÏve TO BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
James Benjamin Galloway, Sofía Ramiro, Lídia Sànchez-Riera, Mary Jane Cadatal, M. Montoro
0citations -
POS0155 CHOICE AND EFFECTIVENESS OF SECOND DMARDS AFTER MTX: COMPARING BIOLOGICAL, TARGETED, AND CONVENTIONAL OPTIONS IN EUROPEAN RA COHORTS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
D. Di Giuseppe, Nils Steinz, J. Sexton, C.A. Hana, H. Lechner-Radner, Daniela Sieghart, +3 more
0citations